{"name": "CN Creative",
 "permalink": "cn-creative",
 "crunchbase_url": "http://www.crunchbase.com/company/cn-creative",
 "homepage_url": "http://www.cncbio.co.uk/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@cncbio.com",
 "phone_number": "+44 (0) 845 544 1651",
 "description": "",
 "created_at": "Fri Jan 27 03:46:12 UTC 2012",
 "updated_at": "Fri Jan 27 03:46:11 UTC 2012",
 "overview": "\u003Cp\u003EHeadquartered in the Bioscience Incubator at Manchester University in the UK, CN Creative provides innovative and sustainable solutions to global problems arising from smoking and smoking-related illnesses. It has developed a distinctive portfolio of products and services focused on smoking cessation and harm reduction, including user-friendly nicotine delivery systems and patient-focused smoking cessation and support services. CNC\u0026#8217;s diverse products include QuitDirect, an NHS-accredited supplier of comprehensive smoking cessation services, the Intellicig\u00ae electronic cigarette, ECOpure proprietary high purity nicotine preparations and NRT Direct, which provides traditional nicotine replacement therapy products and patient support services to publicly and privately sponsored smoking cessation programmes. CNC\u0026#8217;s Nicadex(TM) electronic inhaler nicotine replacement therapy product is in clinical development for use as part of medically supervised smoking cessation programmes.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[98,
       66],
      "assets/images/resized/0017/1834/171834v1-max-150x150.png"],
     [[98,
       66],
      "assets/images/resized/0017/1834/171834v1-max-250x250.png"],
     [[98,
       66],
      "assets/images/resized/0017/1834/171834v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u00a32M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.e-cigarette-forum.com/forum/e-cigarette-suppliers-forum/261589-cn-creative-raises-series-funding-develop-first-medically-approved-electronic-inhaler-nicotine-replacement-therapy-smoking-cessation.html",
    "source_description": "CN Creative raises \u2018Series A\u2019 funding to develop first medically approved electronic inhaler nicotine replacement therapy for smoking cessation ",
    "raised_amount": 2000000.0,
    "raised_currency_code": "GBP",
    "funded_year": 2012,
    "funded_month": 1,
    "funded_day": 26,
    "investments":
     [{"company":
        {"name": "Advent Life Sciences",
         "permalink": "advent-life-sciences",
         "image": null},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Bioscience Incubator",
    "address2": "48 Grafton Street",
    "zip_code": "M13 9XX",
    "city": "Manchester",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}